Sildenafil Citrate Tablet
Product Images NDC 68788-8804

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68788-8804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Tablets 100mg (Sildenafil Citrate 100 mg 500s)

Sildenafil Tablets 100mg (Sildenafil Citrate 100 mg 500s)
Label for Sildenafil Tablets 100 mg by Preferred Pharmaceuticals Inc., generic for Viagra. The label includes dosage and packaging information, storage warnings, and instructions in English and Spanish. It lists the manufacturer as Umedica Laboratories Pvt. Ltd., with barcode and QR code present, and caution against transferring the drug to others.*
FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)
Line graph showing the mean change from baseline in sitting systolic blood pressure over 24 hours after dosing with Sildenafil Citrate 100 mg compared to placebo in healthy volunteers. The x-axis represents time post dose in hours, and the y-axis shows the change in systolic blood pressure in mmHg.*
FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)
A line graph depicting mean standing systolic blood pressure change from baseline over time postdose in hours. Two data sets are shown: Doxazosin plus placebo and Doxazosin plus Sildenafil 25 mg, with blood pressure changes plotted along the vertical axis and time along the horizontal axis.*
FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)
A line graph depicting mean standing systolic blood pressure change from baseline over an 8-hour period. Two data series are shown: Doxazosin plus Placebo represented by blue circles, and Doxazosin plus Sildenafil 50 mg represented by black diamonds. The y-axis shows change in systolic blood pressure (mmHg), and the x-axis shows time postdose in hours.*
FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)
A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing data over 8 hours after dosing. It compares the effects of Doxazosin with 100 mg Sildenafil and Doxazosin with placebo on systolic blood pressure (mmHg), with time on the x-axis and blood pressure change on the y-axis.*
FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)
A line graph showing mean plasma concentrations of Sildenafil over time in healthy male volunteers after treatment with a commercial tablet. The x-axis represents time post-dose in hours, and the y-axis shows plasma concentration in ng/mL, illustrating the drug's absorption and elimination profile.*
FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)
Two bar graphs comparing the effect of sildenafil citrate and placebo on maintenance of erection by baseline score. The graphs display percentages of patients at endpoint across baseline scores from 0 to 5, with multiple bars in each group representing categories labeled 0 through 5. The top graph shows sildenafil citrate results, and the bottom graph shows placebo results.*
FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)
A bar chart showing the percentage of patients reporting improvement by treatment group. The groups include Placebo, Sildenafil citrate 25 mg, Sildenafil citrate 50 mg, and Sildenafil citrate 100 mg, with increasing percentages of reported improvement moving from placebo to the highest dose of Sildenafil citrate.*
FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

Sildenafil-citrate-structure (Sildenafil Citrate Structure)
Chemical structure of sildenafil citrate, illustrating its molecular components and configuration as related to the active pharmaceutical ingredient in the drug product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.